CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- 4 Returned to the company EVP, Chief Financial Officer returned 4,012 shares (to the company)
- 8-K Event Executive or director change · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- S-8 POS Other Post-effective Amendment
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 10-K/A Report 10-K/A
- 8-K Event Other events
- 8-K Event Delisting notice
- 8-K Event Restatement
- 4 Shares withheld for taxes EVP, Ext Aff, GC, Corp Sec gave up 413 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Products Business gave up 566 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Bioservices gave up 632 shares (to pay taxes)
- NT 10-Q Other NT 10-Q
Page 14 of 87 · 1,733 filings